Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TOSYMRA ®safely and effectively. See full prescribing information for TOSYMRA ®. TOSYMRA ®(sumatriptan) nasal spray Initial U.S. Approval: 1992
Medication labelWhy this: Advisory · dailymed-prescription
TOSYMRA is indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: Use only if a clear diagnosis of migraine has been established. If a patient has no response to the first migraine attack treated with TOSYMRA, reconsider the diagnosis before TOSYMRA is administered to treat any subsequent attacks. TOSYMRA is not indicated for the preventive treatment of migraine. TOSYMRA is not indicated for the treatment of cluster headache.
- generic_name
- sumatriptan
- product_names
- sumatriptan
- ndc
- 0245-0812, 0245-0812-59, 0245-0812-89, 0245-0812-61
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en